79950 Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 

produced in each Subject Country, and 

such merchandise from other countries. 

(13) (OPTIONAL) A statement of 

whether you agree with the above 

definitions of the Domestic Like Product 

and Domestic Industry; if you disagree 

with either or both of these definitions, 

please explain why and provide 

alternative definitions. 

Authority: This proceeding is being 

conducted under authority of Title VII 

of the Tariff Act of 1930; this notice is 

published pursuant to § 207.61 of the 

Commission’s rules. 

By order of the Commission. 

Issued: September 25, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–22441 Filed 9–30–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1434] 

Bulk Manufacturer of Controlled 

Substances Application: Curia 

Wisconsin, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Curia Wisconsin, Inc., has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before December 2, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before December 2, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on August 22, 2024, Curia 

Wisconsin, Inc., 870 Badger Circle, 

Grafton, Wisconsin 53024–0000, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

Lysergic acid diethylamide ..................................................................................................................................................... 7315 I 

Tetrahydrocannabinols ........................................................................................................................................................... 7370 I 

4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................. 7392 I 

3,4-Methylenedioxyamphetamine ........................................................................................................................................... 7400 I 

3,4-Methylenedioxymethamphetamine ................................................................................................................................... 7405 I 

5-Methoxy-N-N-dimethyltryptamine ........................................................................................................................................ 7431 I 

Dimethyltryptamine ................................................................................................................................................................. 7435 I 

Psilocybin ............................................................................................................................................................................... 7437 I 

Psilocyn .................................................................................................................................................................................. 7438 I 

Lisdexamfetamine .................................................................................................................................................................. 1205 II 

Methylphenidate ..................................................................................................................................................................... 1724 II 

Amobarbital ............................................................................................................................................................................ 2125 II 

Nabilone ................................................................................................................................................................................. 7379 II 

4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ........................................................................................................................... 8333 II 

Opium extracts ....................................................................................................................................................................... 9610 II 

Opium, powdered ................................................................................................................................................................... 9639 II 

Opium, granulated .................................................................................................................................................................. 9640 II 

Opium poppy .......................................................................................................................................................................... 9650 II 

Noroxymorphone .................................................................................................................................................................... 9668 II 

Fentanyl .................................................................................................................................................................................. 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the purpose of analytical 

reference standards or for sale to its 

customers. In reference to the drug code 

7370 (Tetrahydrocannabinols), the 

company plans to bulk manufacture as 

synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Marsha L. Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–22446 Filed 9–30–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1435] 

Importer of Controlled Substances 

Application: Fresenius Kabi USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Fresenius Kabi USA, LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 31, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 31, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 


khammond on DSKJM1Z7X2PROD with NOTICES